The tumor-specific effect of ICT can be achieved by active targeting via the receptor-ligand interaction between HA and CD44 plus passive targeting by accumulation around tumors due to the Enhanced Permeability and Retention (EPR) effect. Here, CD44 is linked to neoplasm.